Home>Topics>>UPDATE 1-OPKO Health to buy Israel's Prolor Biotech for $480 mln

UPDATE 1-OPKO Health to buy Israel's Prolor Biotech for $480 mln

Reuters: Hot Stocks

Wed, 24 Apr 2013

* Prolor's hGH-CTP has completed four clinical trials (Adds CEO quotes, details, share reaction)

Related Topics:

  1. Biotechnology
  2. Chief Executive
Content Partners